Vera S. Byers

3.9k total citations · 1 hit paper
80 papers, 3.0k citations indexed

About

Vera S. Byers is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vera S. Byers has authored 80 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 20 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vera S. Byers's work include Toxin Mechanisms and Immunotoxins (23 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Transgenic Plants and Applications (11 papers). Vera S. Byers is often cited by papers focused on Toxin Mechanisms and Immunotoxins (23 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Transgenic Plants and Applications (11 papers). Vera S. Byers collaborates with scholars based in United States, United Kingdom and France. Vera S. Byers's co-authors include Alan S. Levin, R W Baldwin, GB McDonald, L Fisher, FR Appelbaum, Gary Schoch, PJ Martin, Eli E. Sercarz, JA Hansen and R Storb and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Vera S. Byers

78 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1991 456 citations Vera S. Byers et al. profile →

Peers

Countries citing papers authored by Vera S. Byers

Since Specialization

Citations

This map shows the geographic impact of Vera S. Byers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera S. Byers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera S. Byers more than expected).

Fields of papers citing papers by Vera S. Byers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera S. Byers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera S. Byers. The network helps show where Vera S. Byers may publish in the future.

Co-authorship network of co-authors of Vera S. Byers

This figure shows the co-authorship network connecting the top 25 collaborators of Vera S. Byers. A scholar is included among the top collaborators of Vera S. Byers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera S. Byers. Vera S. Byers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perfluoroalkyl substances exposure in firefighters: Sources and implications 2022 ·Environmental Research ·(unknown), (unknown), Linda L Remy, Vera S. Byers, (unknown), (unknown), (unknown), (unknown)	42
2	Hospital, health, and community burden after oil refinery fires, Richmond, California 2007 and 2012 2019 ·Environmental Health ·Linda L Remy, Ted Clay, Vera S. Byers, Paul Rosenfeld	6
3	Reproductive outcomes after non-occupational exposure to hexavalent chromium, Willits California, 1983-2014 2017 ·Environmental Health ·Linda L Remy, Vera S. Byers, Ted Clay	34
4	Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis 2012 ·The American Journal of Gastroenterology ·William J. Sandborn, Stephan R. Targan, Vera S. Byers, Dean Rutty, Hua Mu, Xun Zhang, Tom Tang	115
5	Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine 2010 ·Alimentary Pharmacology & Therapeutics ·Tom Tang, Stephan R. Targan, (unknown), Cheng Xu, Vera S. Byers, William J. Sandborn	88
6	A Phase II Study of Effect of Addition of Trichosanthin to Zidovudine in Patients with HIV Disease and Failing Antiretroviral Agents 1994 ·AIDS Research and Human Retroviruses ·Vera S. Byers, Alan S. Levin, (unknown), (unknown), R. A. Robins, R W Baldwin	73
7	Neurological reactions in HIV‐infected patients treated with trichosanthin 1993 ·Neuropathology and Applied Neurobiology ·Paul A. Garcia, (unknown), Harry V. Vinters, (unknown), Rachel Williams, James O. Kahn, Vera S. Byers, Alan S. Levin, (unknown), Robert O. Messing	15
8	Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies 1993 ·Journal of Clinical Immunology ·Vera S. Byers, Eric Austin, J. A. Clegg, (unknown), Barbara Gunn, Doreen Hooi, Ferenc Hudecz, Michael R. Price, Robert W. Baldwin	3
9	Targeted kill: From umbrellas to monoclonal antibodies 1992 ·Journal of Clinical Immunology ·Vera S. Byers, Robert W. Baldwin	17
10	Monoclonal antibodies and immunoconjugates in cancer treatment 1990 ·R. W. Baldwin, Vera S. Byers, Ronald D. Mann	1
11	Monoclonal antibody immunoconjugates for cancer treatment 1989 ·Current Opinion in Immunology ·R W Baldwin, Vera S. Byers	6
12	Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes. 1988 ·The Journal of Immunology ·Vera S. Byers, (unknown), (unknown), Lisa Durrant, R. A. Robins, Martin C. Garnett, M.R. Price, R W Baldwin	12
13	Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia 1988 ·Cancer Immunology Immunotherapy ·Vera S. Byers, Alan S. Levin, David Ozonoff, R. W. Baldwin	91
14	Monoclonal antibody 791t 36 ricin a chain immunotoxin in the treatment of colorectal cancer 1987 ·British Journal of Cancer ·Vera S. Byers, Robert Rodvien, Kathleen A. Grant, R W Baldwin	1
15	Monoclonal antibody drug targeting 1987 ·Investigational New Drugs ·R W Baldwin, Vera S. Byers	8
16	Circulating immune complexes in patients with bone tumours 1980 ·International Journal of Cancer ·(unknown), R. A. Robins, R. W. Baldwin, Vera S. Byers	20
17	Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma. 1975 ·PubMed ·Vera S. Byers, Alan S. Levin, James O. Johnston, Adeline J. Hackett	36
18	INDUCTION AND REVERSAL OF IMMUNE PARALYSIS IN VITRO 1970 ·The Journal of Experimental Medicine ·Vera S. Byers, Eli E. Sercarz	21
19	THE X-Y-Z SCHEME OF IMMUNOCYTE MATURATION 1968 ·The Journal of Experimental Medicine ·Vera S. Byers, Eli E. Sercarz	10
20	THE X-Y-Z SCHEME OF IMMUNOCYTE MATURATION 1968 ·The Journal of Experimental Medicine ·Vera S. Byers, Eli E. Sercarz	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact